Prognostic PET/CT Model in Non Small Cell Lung Cancer

Prospective validation of a prognostic model based on advanced PET/CT image analysis in non small cell lung cancer

Completed

Looking for future studies?

Key information

Conditions

Non Small Cell Lung Cancer Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Poitiers

Poitiers, France

About this study

Validation on a prospective cohort of patient of a predictive model for survival based on image derived parameters

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

non small cell lung cancer
initial fluorodeoxygluoces (FDG) PET/CT before treatment

Exclusion criteria

none

Treatment and study plan

Primary outcomes

validation of a multiparametric PET/CT prognostic model

Time frame: 18 months

overall survival rate

Sponsors and collaborators

Lead sponsor

Poitiers University Hospital

Other

Collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Registry information

Official study title

Prognostic Positron Emission Tomography/Computed Tomogrpahy Model in Non Small Cell Lung Cancer

Important dates

Study start: 2016
Primary completion: 2019
Study completion: 2019
First posted: Jun 27, 2017
Registry last updated: Apr 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed